A detailed history of Srs Capital Advisors, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 18 shares of INSM stock, worth $1,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 25 28.0%
Holding current value
$1,311
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$22.0 - $69.71 $154 - $487
-7 Reduced 28.0%
18 $1,000
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $16 - $21
1 Added 4.17%
25 $0
Q4 2022

Feb 24, 2023

BUY
$16.98 - $23.15 $407 - $555
24 New
24 $0

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.87B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.